O EGFRvIII mutation, the degree of AREG expression identifies HNSCC patients
Chemexpress O EGFRvIII mutation, the level of AREG expression identifies HNSCC sufferers that are not responsive to combined cetuximab and docetaxel therapy. In agreement with this observation,16 we’ve got recently reported…